Study of circulating antibodies against CD25 and FOXP3 in breast cancer

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 3779-3783

  Liu, Tong ^a   Song, Yan Ni ^a   Shi, Qing Yu ^a   Liu, Yang ^a   Bai, Xia Nan ^a   Pang, Da ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Autoantibody; Biomarker; Breast cancer; CD25; FOXP3; Tumor immunity

Indexed keywords

ANTIBODY CD25; ANTIBODY FOXP3; AUTOANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STUDENT T TEST;

ADULT; AUTOANTIBODIES; BREAST NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84898808245     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1500-x     Document Type: Article

References (25)

1. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2006;1:513-9.
2. Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2007;18:868-73.
3. Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. The FEBS journal. 2009;276:6880-904.
4. Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, et al. Earlycdt-lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer prevention research. 2011;4:1126-34.
5. Chapman CJ, Healey GF, Murray A, Boyle P, Robertson C, Peek LJ, et al. Earlycdt(r)-lung test: improved clinical utility through additional autoantibody assays. Tumor biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:1319-26.
6. Piura E, Piura B. Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma. Journal of oncology. 2011;2011:982425.
7. Ye H, Sun C, Ren P, Dai L, Peng B, Wang K, et al. Mini-array of multiple tumor-associated antigens (taas) in the immuno-diagnosis of breast cancer. Oncology letters. 2013;5:663-8.
8. Ye L, Li X, Sun S, Guan S, Wang M, Guan X, Lee KH, Wei J, Liu B: A study of circulating anti-cd25 antibodies in non-small cell lung cancer. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012
9. Ye L, Guan S, Zhang C, Lee KH, Sun S, Wei J, Liu B: Circulating autoantibody to foxp3 may be a potential biomarker for esophageal squamous cell carcinoma. Tumor biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 2013
10. Guan S, Liu B, Zhang C, Lee KH, Sun S, Wei J: Circulating autoantibody to cd25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2013
11. Redpath M, Xu B, van Kempen LC, Spatz A. The dual role of the x-linked Foxp3 gene in human cancers. Molecular oncology. 2011;5:156-63.
12. Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, et al. Tumor-evoked regulatory b cells promote breast cancer metastasis by converting resting Cd4(+) T cells to T regulatory cells. Cancer research. 2011;71:3505-15.
13. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA: a cancer journal for clinicians. 2011;61:409-18.
14. Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of who mortality database. Bmj. 2010;341:c3620.
15. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-61.
16. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of Cd4+Cd25+ regulatory T cells. Nature immunology. 2003;4:330-6.
17. Karanikas V, Speletas M, Zamanakou M, Kalala F, Loules G, Kerenidi T, et al. Foxp3 expression in human cancer cells. Journal of translational medicine. 2008;6:19.
18. Wolf AM, Rumpold H, Wolf D, Gastl G, Reimer D, Jenewein N, et al. Role of forkhead box protein 3 expression in invasive breast cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007;25:4499-500. author reply 4500-4491.
19. Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Menard S, et al. Foxp3 expression and overall survival in breast cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2009;27:1746-52.
20. Ebert LM, Tan BS, Browning J, Svobodova S, Russell SE, Kirkpatrick N, et al. The regulatory T cell-associated transcription factor Foxp3 is expressed by tumor cells. Cancer research. 2008;68:3001-9.
21. Zhang HY, Sun H. Upregulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer letters. 2010;287:91-7.
22. Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, et al. Foxp3 is an x-linked breast cancer suppressor gene and an important repressor of the Her-2/Erbb2 oncogene. Cell. 2007;129:1275-86.
23. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated t cells expressing il-2 receptor alpha-chains (cd25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of immunology. 1995;155:1151-64.
24. Li CH, Kuo WH, Chang WC, Huang SC, Chang KJ, Sheu BC. Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer. Immunologic research. 2011;51:71-9.
25. Erfani N, Mehrabadi SM, Ghayumi MA, Haghshenas MR, Mojtahedi Z, Ghaderi A, et al. Increase of regulatory T cells in metastatic stage and ctla-4 overexpression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung cancer. 2012;77:306-11.